Table 3.
Treatment | PR (%) | SD (%) | PD (%) | ORR (%) | CBR (%) | CA125 response (%) |
---|---|---|---|---|---|---|
Tamoxifen (n = 43) | 6 (14) | 22 (51.2) | 15 (34.9) | 6 (14) | 28 (65.1) | 10 (23.3) |
Letrozole (n = 54) | 8 (14.8) | 22 (40.7) | 24 (44.4) | 8 (14.8) | 30 (55.6) | 12 (22.2) |
Total (n = 97) | 14 (14.4) | 44 (45.4) | 39 (40.2) | 14 (14.4) | 58 (59.8) | 22 (22.7) |
Abbreviations: CBR clinical benefit rate, ORR objective response rate, PD progressive disease, PR partial response, SD stable disease